Diadema Partners »

Replimune Group shares owned by Diadema Partners

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6M 612k 4.19

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Replimune Group

Baker Bros. Advisors
Rtw Investments
BlackRock
Fcpm Iii Services B.v.
Point72 Asset Management
Ally Bridge Group
Susquehanna International
Vanguard Group
Tang Capital Management
State Street Corporation
Braidwell
Balyasny Asset Management
Readystate Asset Management
Millennium Management
Geode Capital Management

View all funds holding Replimune Group